We perform cytotoxicity tests of medical devices by ISO 10993-5

Do you know that we perform cytotoxicity tests of medical devices by ISO 10993-5 every day, which are used to register products in many markets?

The basis for the success of this study is the selection of the appropriate methodology because medical devices are fundamentally different from each other: intended use, composition, operation etc.

If your company needs a product test comparison – we invite you to cooperate!

See more

ISO 10993-1:2025: Enhanced Characterization, Clearer Risk Logic

The 2025 revision keeps biological evaluation firmly inside ISO 14971 risk management and across the full device life cycle. Your…

ISO 10993-1:2025: Risk Management Integration and Exposure Duration

ISO 10993-1:2025 embeds the biological evaluation within ISO 14971’s risk-management framework. The standard explicitly requires identifying biological hazards, estimating their…

Preparing for Biocompatibility Testing: Strategic Considerations for Medical Device Manufacturers

Biocompatibility testing is essential for every medical device, ensuring safety, regulatory approval, and market success. The process, however, can be…

In Vitro & In Vivo: Strategic Insights for Medical Device Leaders

Biocompatibility testing is not just a regulatory requirement—it is a cornerstone of medical device safety, market approval, and long-term trust….

Biocompatibility Requirements for Wearable Medical Devices: Unique Considerations

Wearable medical devices are transforming healthcare with continuous monitoring, real-time diagnostics, and improved patient engagement. However, their design introduces distinct…

Proactive Planning: Combining Biocompatibility with Other Preclinical Testing Needs

Biocompatibility testing is a vital part of preclinical evaluation, but it’s just one piece of the larger puzzle. Manufacturers often…